U.S. Markets closed

TABLE-India's Sun Pharma Sept-qtr net profit surges

Nov 13 (Reuters) - Three months ended Sept. 30

Net Profit 13.62 3.2

Net Sales 41.92 26.57

Results are consolidated

NOTE: Sun Pharmaceuticals is engaged in manufacture

of formulations in the psychiatry, cardio-vascular and

neurology segments.